Prostate Cancer: Clinical Trials

2209 completed, 624 recruiting, 545 unknown, 423 terminated. 1343 Not applicable, 1284 Phase 2, 662 Phase 1, 428 Phase 3, 86 Phase 4.

By phase and status

Phase	Trials	Status
Not applicable	1343	Completed 588, Unknown 217, Recruiting 206, Active not recruiting 111, Terminated 84, Not yet recruiting 65, Withdrawn 52, Enrolling by invitation 14, Suspended 6
Phase 2	1284	Completed 668, Terminated 186, Recruiting 142, Unknown 108, Active not recruiting 82, Withdrawn 59, Not yet recruiting 34, Suspended 4, Enrolling by invitation 1
Phase 1	662	Completed 360, Terminated 92, Recruiting 81, Unknown 51, Active not recruiting 42, Withdrawn 18, Not yet recruiting 14, Suspended 3, Enrolling by invitation 1
Phase 3	428	Completed 232, Recruiting 48, Terminated 48, Unknown 42, Active not recruiting 35, Withdrawn 12, Not yet recruiting 7, Enrolling by invitation 2, Suspended 2
Phase 4	86	Completed 49, Unknown 9, Recruiting 8, Terminated 8, Active not recruiting 4, Not yet recruiting 4, Suspended 2, Enrolling by invitation 1, Withdrawn 1
Early Phase 1	74	Completed 31, Recruiting 10, Unknown 10, Active not recruiting 7, Not yet recruiting 6, Terminated 5, Withdrawn 5

Follow Prostate Cancer: new trials by email Literature Review of Prostate Cancer trials Research Report on Prostate Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
PROstate Cancer Risk Calculator for ACTionable Clinical Decision-making in Nigeria (a) Training and (b) Supported risk assessment - Prostate Cancer, Risk Assessment	Not applicable	Not yet recruiting	Ahmadu Bello University	89	2029-03-01	2026-07-29
A Phase 1/2 Study of Personalized PSMA Radiopharmaceutical Therapy 177Lu-PSMA-I&T - escalating renal absorbed dose, 177Lu-PSMA-I&T - recommended phase 2 regime - Cancer, Prostate Cancer	Phase 1 / Phase 2	Not yet recruiting	CHU de Quebec-Universite Laval	500	2028-03-01	2025-03-30
Understanding the Role of MyCareGorithm as a Visual Digital Platforms in Cancer Treatment Education and Patient Comprehension of Oncology Treatment Plans Survey - Head and Neck Cancer, Prostate Cancer	Not applicable	Not yet recruiting	M.D. Anderson Cancer Center	94	2027-03-01	2026-10-01
Prostate Stereotactic Radiation and Radio-induced Lymphocyte Apoptosis for Predicting Late Toxicities in Prostate Cancer (PROSTERA) Radio-induced Lymphocyte Apoptosis (RILA) Assay, Stereotactic body radiotherapy (SBRT) - Prostate Cancer	Not applicable	Not yet recruiting	Clinique Sainte Clotilde	220	2027-02-01	2026-10-26
iCCARE Project #4: Grounded Theory Study of the Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men Diagnosed With Prostate Cancer Interviews - Prostate Cancer	Not applicable	Not yet recruiting	M.D. Anderson Cancer Center	40	2027-01-31	2026-10-06
HRT-PC Trial: Hormone Recovery After Treatment for Prostate Cancer Trial. An Open-label Phase II Study of Clomiphene Citrate in Patients With Persistent Hypogonadism After ADT for Treatment of Localized Prostate Cancer Clomiphene Citrate 25mg - Prostate Cancer	Phase 2	Not yet recruiting	University of Nebraska	83	2027-01-31	2026-10-20
Quality and Safety of Real-Time Brachytherapy Treatments: Clinical Implementation of a Multipoint Scintillation Detector for Treatment Monitoring Brachytherapy treatment monitoring using a plastic scintillation detector - Prostate Cancer, Gynecologic Cancers	Not applicable	Not yet recruiting	CISSS de Chaudière-Appalaches	25	2027-01-15	2026-10-21
Veteran Peer Navigators to Promote Shared Decision Making for PSA Screening Veteran Peer Decision Coaching Session for PSA Screening - Prostate Cancer	Not applicable	Not yet recruiting	VA Office of Research and Development	228	2027-01-04	2026-10-21
ALSO-PERFORM Study. ALternating Stereotaxic Or PElvic Radiotherapy FOR Metachronic Metastatic Prostate Cancer Prostate Cancer		Not yet recruiting	Amsterdam UMC, location VUmc	130	2027-01-01	2026-10-08
Weekly Online CT or MR Adaptive Definitive SBRT for Regionally Metastatic Prostate Cancer weekly CT or MR online adaptive definitive SBRT - Prostate Cancer	Not applicable	Not yet recruiting	University of Zurich	54	2027-01-01	2026-08-21
Clinical Trial to Observe the Effects of Tamoxifen on Testosterone Recovery in Medically Castrated Prostate Cancer Patients Tamoxifen - Hypogonadism, Prostate Cancer	Phase 2	Recruiting	University Health Network, Toronto	96	2026-12-31	2026-10-22
Evaluation of a Prostate-Targeted PET Imaging System (P-PET) for Detecting Prostate Cancer Prostate-Targeted PET- Scan (P-PET). - Prostate Cancer	Not applicable	Not yet recruiting	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	25	2026-12-30	2026-09-25
Training on Systemic and Organ Spec. PM in PC Exercise - Prostate Cancer	Not applicable	Not yet recruiting	Massachusetts General Hospital	20	2026-12-10	2026-08-17
Prostate Cancer in UK Prisons: A Retrospective Data Analysis Prostate Cancer		Not yet recruiting	Royal Marsden NHS Foundation Trust	9007	2026-12-03	2026-10-16
COQ10 and Vitamin E for Off-Target Radiation Toxicity Coenzyme Q10 Cap/Tab, Vitamin E Cap/Tab - Prostate Cancer, Uterine Cancer	Phase 1 / Phase 2	Not yet recruiting	University of Nebraska	200	2026-12-01	2026-10-08
Identifying the Best Follow up Approach for People Who Have Had Treatment to Cure Newly Diagnosed Prostate Cancer Hospital based follow up, Primary care based follow up, Planned shared care follow up - Prostate Cancer		Not yet recruiting	Imperial College London	100000	2026-12-01	2026-10-06
Testing Pasritamig Before Surgery for the Treatment of Localized Prostate Cancer Pasritamig - Prostate Cancer	Phase 1	Not yet recruiting	Fred Hutchinson Cancer Center	18	2026-11-30	2026-10-06
Sipuleucel-T (Sip-T) in Combination With N-803 in Metastatic Androgen Pathway Modulation Resistant (mAPMR) Prostate Cancer Sipuleucel-T, N803 - Prostate Cancer, Metastatic Prostate Cancer	Phase 1	Not yet recruiting	Washington University School of Medicine	30	2026-11-30	2026-08-10
Exercise-induced Steroid Changes in Active Surveillance for Prostate Cancer High-Intensity Interval Training (HIIT) Exercise - Prostate Cancer	Not applicable	Recruiting	University of Miami	50	2026-11-30	2026-10-23
Telemedicine-mHealth Symptom Cluster Intervention for Advanced Cancer Patients: Finding Our Center Under Stress (FOCUS) mHealth Intervention - Lung Cancer, Breast Cancer	Not applicable	Suspended	Ohio State University Comprehensive Cancer Center	120	2026-11-15	2026-08-17

Showing 20 of 4516. Sign in to see all of them.

Narrower conditions

Prostatic Neoplasms (4516)  ·  Breast Neoplasms (351)  ·  Neoplasms (257)  ·  Lung Neoplasms (175)  ·  Colorectal Neoplasms (159)  ·  Neoplasm Metastasis (147)  ·  Ovarian Neoplasms (138)  ·  Urinary Bladder Neoplasms (109)  ·  Pancreatic Neoplasms (104)  ·  Carcinoma, Non-Small-Cell Lung (99)  ·  Head and Neck Neoplasms (87)  ·  Kidney Neoplasms (86)  ·  Colonic Neoplasms (82)  ·  Melanoma (67)  ·  Esophageal Neoplasms (65)

Broader conditions

Genital Diseases (4513)  ·  Urogenital Diseases (4513)  ·  Genital Diseases, Male (4509)  ·  Male Urogenital Diseases (4507)  ·  Neoplasms by Site (4506)  ·  Genital Neoplasms, Male (4503)  ·  Urogenital Neoplasms (4493)  ·  Prostatic Diseases (4487)  ·  Neoplasms (4259)  ·  Pathological Conditions, Signs and Symptoms (489)  ·  Skin and Connective Tissue Diseases (387)  ·  Skin Diseases (383)  ·  Breast Diseases (364)  ·  Female Urogenital Diseases (347)  ·  Female Urogenital Diseases and Pregnancy Complications (347)

Interventions

Docetaxel (187)  ·  Prednisone (143)  ·  Leuprolide (136)  ·  Radiotherapy (134)  ·  Goserelin (104)  ·  bicalutamide (104)  ·  enzalutamide (103)  ·  Abiraterone Acetate (86)  ·  acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide (83)  ·  Androgen Antagonists (77)  ·  Radiosurgery (67)  ·  Surveys and Questionnaires (59)  ·  Magnetic Resonance Spectroscopy (58)  ·  Gonadotropin-Releasing Hormone (49)  ·  gallium 68 PSMA-11 (49)

Sponsors

Memorial Sloan Kettering Cancer Center (128)  ·  National Cancer Institute (NCI) (89)  ·  M.D. Anderson Cancer Center (83)  ·  University Health Network, Toronto (61)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (57)  ·  Dana-Farber Cancer Institute (54)  ·  University of California, San Francisco (46)  ·  Ferring Pharmaceuticals (41)  ·  Duke University (40)  ·  AstraZeneca (37)  ·  Weill Medical College of Cornell University (36)  ·  Chinese University of Hong Kong (34)  ·  Case Comprehensive Cancer Center (32)  ·  NYU Langone Health (31)  ·  University of Wisconsin, Madison (31)

Countries

United States (2322)  ·  Canada (451)  ·  France (291)  ·  United Kingdom (290)  ·  China (255)  ·  Italy (189)  ·  Germany (182)  ·  Netherlands (166)  ·  Spain (139)  ·  Belgium (132)  ·  Australia (125)  ·  South Korea (94)  ·  Denmark (87)  ·  Switzerland (84)  ·  Sweden (77)

Top investigators

Mary-Ellen Taplin, MD (14)  ·  Chi Fai NG, MD (12)  ·  Michael Morris, MD (12)  ·  Rahul Aggarwal, MD (12)  ·  Peter A Pinto, M.D. (9)  ·  James Eastham, MD (8)

Results publications

PMID 34350976, PMID 33270906, PMID 33465252, PMID 24722180, PMID 25712310, PMID 25819287, PMID 36884035, PMID 38320143, PMID 38421252, PMID 22747660, PMID 25592642, PMID 27626136, PMID 32994091, PMID 24423462, PMID 25614256, PMID 25754526, PMID 26512712, PMID 27626365, PMID 29272162, PMID 36383907, PMID 36596347, PMID 37070660, PMID 38421243, PMID 40645505, PMID 41698328, PMID 17182834, PMID 18212313, PMID 19637244, PMID 20122025, PMID 20818327, PMID 20964826, PMID 21149658, PMID 21751904, PMID 21917607, PMID 22056152, PMID 22547274, PMID 22958524, PMID 23000088, PMID 23158413, PMID 23228299, PMID 23411385, PMID 24072344, PMID 24101042, PMID 24207135, PMID 24297031, PMID 24412228, PMID 24590644, PMID 24881730, PMID 24957547, PMID 24974051

NIH funding

2017 (16), 2023 (16), P30CA072720 (13), U10CA031946 (13), 2016 (12), P30CA022453 (11), 2019 (10), P30CA043703 (10), 2008 (9), 2025 (9), 2014 (8), P30CA008748 (8), P30CA016672 (8), 2009 (7), P30CA012197 (7)